TODAY'S HEADLINES

Controversy surrounds abortion pill access

Soon after FDA expanded access to the "abortion pill" or mifepristone (Mifeprex, Danco Laboratories), some states may be combating the decision. Read more

5 facts to know about the new asthma drug

FDA recently approved reslizumab (Cinqair, Teva Pharmaceuticals), an injectable used with other asthma medicines for the maintenance treatment of severe asthma. Here are the top 5 facts to know about Cinqair. Read more

CONTINUING PHARMACY EDUCATION

Part 2: Law: Educating and empowering patients and caregivers: The pharmacist's role in reducing the risk of opioid overdose

This month's CE activity is open for pharmacists and pharmacy technicians. "Part II: Law: Educating and empowering patients and caregivers: The pharmacist's role in reducing the risk of opioid overdose." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Brand and specialty drug spending spikes

Spending on brand name drugs spiked 16.2% in 2015 and 98.2% since 2011, according to a new report from pharmacy benefit manager (PBM) Express Scripts. Plus, specialty medications remain a key contributor to drug spending. Read more

April 08, 2016

Related Articles

Lutera is latest birth control recall

Class action suit targets asthma drug